93 related articles for article (PubMed ID: 10945007)
1. [Japan Adult Leukemia Study Group (JALSG)--twelve years of activities and future direction].
Tomonaga M
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1133-8. PubMed ID: 10945007
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Oncology Groups in Japan: experience of the Japan Adult Leukemia Study Group (JALSG)].
Ohno R
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2519-24. PubMed ID: 8279850
[TBL] [Abstract][Full Text] [Related]
3. [The role of the Japan Clinical Oncology Group].
Ohe Y; Saijo N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1127-32. PubMed ID: 10945006
[TBL] [Abstract][Full Text] [Related]
4. [Tuberculosis and its control--lessons from the past and future prospect].
Shimao T
Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
[TBL] [Abstract][Full Text] [Related]
5. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
Tobisu K
Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
[TBL] [Abstract][Full Text] [Related]
6. Trisomy 11 acute myeloid leukemia: 5 additional cases from the Japan Adult Leukemia Study Group AML-92 and AML-95 databases.
Suzuki A; Ohyashiki K; Kimura Y; Yamada H; Sano F; Miyawaki S; Kuriyama K; Ohno R;
Int J Hematol; 2000 Dec; 72(4):466-9. PubMed ID: 11197213
[TBL] [Abstract][Full Text] [Related]
7. [Post launch studies].
Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
[TBL] [Abstract][Full Text] [Related]
8. Multicenter cooperative study group in hematology in Japan: the 10-year history and role of the Japan Adult Leukemia Study Group in Japan.
Ohno R
Int J Hematol; 1998 Apr; 67(3):213-9. PubMed ID: 9650442
[TBL] [Abstract][Full Text] [Related]
9. A concise history of the cancer and leukemia group B.
Schilsky RL; McIntyre OR; Holland JF; Frei E
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3553s-5s. PubMed ID: 16740784
[TBL] [Abstract][Full Text] [Related]
10. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
Dilts DM; Sandler AB; Baker M; Cheng SK; George SL; Karas KS; McGuire S; Menon GS; Reusch J; Sawyer D; Scoggins M; Wu A; Zhou K; Schilsky RL;
J Clin Oncol; 2006 Oct; 24(28):4553-7. PubMed ID: 17008694
[TBL] [Abstract][Full Text] [Related]
11. [Globalization of clinical trials].
Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
[TBL] [Abstract][Full Text] [Related]
12. [Infrastructure of cancer clinical trial cooperative groups in western countries].
Fukuda H
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. [Present situation and future subjects of N.SAS study--based on experience of managing data center].
Adachi T; Nagaya M; Kawakami T; Hao Y
Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):212-6. PubMed ID: 9987521
[TBL] [Abstract][Full Text] [Related]
15. [Recent progress of clinical trials in urologic oncology].
Hinotsu S
Gan To Kagaku Ryoho; 2006 Feb; 33(2):188-92. PubMed ID: 16484854
[TBL] [Abstract][Full Text] [Related]
16. Internet based multi-institutional clinical research: a convenient and secure option.
Lallas CD; Preminger GM; Pearle MS; Leveillee RJ; Lingeman JE; Schwope JP; Pietrow PK; Auge BK
J Urol; 2004 May; 171(5):1880-5. PubMed ID: 15076298
[TBL] [Abstract][Full Text] [Related]
17. [The present status and prospects for clinical oncology in Japan].
Oshita F; Saijo N
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():281-8. PubMed ID: 7986104
[TBL] [Abstract][Full Text] [Related]
18. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
Hudis CA; Winer EP
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis.
Okamoto T; Kanamaru A; Shimazaki C; Motoji T; Takemoto Y; Takahashi M; Fukushima T; Takeshita A; Kusumoto GS; Kishimoto Y; Yorimitsu S; Tsukuda K; Uike N; Arima N; Ohno R
Int J Hematol; 2000 Aug; 72(2):200-5. PubMed ID: 11039669
[TBL] [Abstract][Full Text] [Related]
20. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
